Short answer
Hepatitis A, B, and C are different viruses, so a result that simply says "hepatitis positive" is not enough. Hepatitis A testing usually separates recent infection from past immunity. Hepatitis B is best interpreted with the triple panel: HBsAg, anti-HBs, and total anti-HBc. Hepatitis C usually starts with an HCV antibody test and needs HCV RNA testing to confirm current infection.
Liver enzymes such as ALT and AST can support the story, but they do not identify the virus. The useful interpretation comes from matching the marker, symptoms, vaccination history, exposure timing, pregnancy status, immune status, and any follow-up RNA or panel results.
Which test answers which question?
| Virus | Common blood-test markers | What they help answer |
|---|---|---|
| Hepatitis A | IgM anti-HAV, IgG anti-HAV, total anti-HAV | Is there evidence of recent hepatitis A, or evidence of past infection or vaccination immunity? |
| Hepatitis B | HBsAg, anti-HBs, total anti-HBc; sometimes IgM anti-HBc or HBV DNA | Is there current infection, past infection, vaccine immunity, susceptibility, acute infection, or a pattern needing more workup? |
| Hepatitis C | HCV antibody followed by HCV RNA NAT when antibody is reactive | Was there past exposure, and is there current active infection? |
Hepatitis A markers
Hepatitis A is often a short-term infection, and CDC says acute HAV infection is usually diagnosed with IgM anti-HAV in the right clinical setting. Total anti-HAV or IgG anti-HAV usually means immunity from past infection or vaccination, not necessarily current illness.
Context matters. CDC surveillance guidance warns that positive IgM anti-HAV results can occur long after infection or as false positives in people without clinical or exposure evidence of recent hepatitis A. If suspicion is high but early IgM testing is negative, repeat testing may be considered.
Hepatitis B triple panel
CDC recommends hepatitis B screening with a triple panel for adults who have never been screened. The panel includes HBsAg, anti-HBs, and total anti-HBc. One marker alone can be misleading because the pattern is what distinguishes current infection, past resolved infection, vaccination immunity, and susceptibility.
| Marker | Plain-English meaning | Common interpretation issue |
|---|---|---|
| HBsAg | Hepatitis B surface antigen | Usually points to current HBV infection, acute or chronic, though recent vaccination can rarely create transient positivity. |
| Anti-HBs | Antibody to hepatitis B surface antigen | Often means immunity from vaccination or recovery, but needs the rest of the panel to separate those possibilities. |
| Total anti-HBc | Total antibody to hepatitis B core antigen | Usually means past or current infection, not vaccination alone. Isolated core antibody patterns may need careful follow-up. |
| IgM anti-HBc | IgM antibody to hepatitis B core antigen | Used when acute or recent HBV infection is suspected, especially with compatible symptoms or HBsAg positivity. |
Hepatitis C antibody and RNA
CDC recommends universal hepatitis C screening for adults 18 and older and for pregnant people during each pregnancy, with more frequent testing for certain ongoing risks. The usual sequence starts with an HCV antibody test. If that test is reactive, HCV RNA testing should be done automatically to determine whether current infection is present.
A reactive HCV antibody with HCV RNA detected means current infection. A reactive antibody with RNA not detected usually means no current infection, although follow-up may be needed after recent exposure, suspected specimen issues, or when distinguishing true positivity from biologic false positivity matters.
Timing, symptoms, and liver enzymes
Testing right after an exposure can miss early infection. For hepatitis C, CDC says if exposure may have occurred within the past 6 months, a clinician should order HCV RNA rather than relying only on an antibody test. For hepatitis A, repeat IgM testing may be needed if suspicion is high early in the illness.
Symptoms and liver chemistry can change urgency. Jaundice, dark urine, pale stools, severe fatigue, fever, nausea, abdominal pain, easy bleeding, confusion, pregnancy, immune suppression, known blood exposure, needle sharing, or a sexual exposure involving blood or hepatitis B risk should be discussed promptly with a clinician. ALT, AST, bilirubin, alkaline phosphatase, GGT, albumin, platelet count, and INR can help show severity and pattern, but they do not replace virus-specific testing.
Questions to ask
- Which virus is being tested: hepatitis A, hepatitis B, hepatitis C, or more than one?
- For hepatitis A, is this IgM anti-HAV, IgG anti-HAV, or total anti-HAV?
- For hepatitis B, was the full triple panel ordered: HBsAg, anti-HBs, and total anti-HBc?
- If total anti-HBc is positive, does the pattern suggest past infection, current infection, isolated core antibody, or another follow-up path?
- For hepatitis C, will a reactive antibody automatically reflex to HCV RNA NAT?
- Was testing done too soon after a possible exposure?
- Do ALT, AST, bilirubin, INR, platelet count, symptoms, pregnancy, or immune status change urgency?
- Do I need vaccination, post-exposure guidance, partner testing, or repeat testing?
FAQ
Is there one blood test for hepatitis A, B, and C?
A hepatitis panel may use one blood draw, but hepatitis A, B, and C require different markers. HAV IgM, the hepatitis B triple panel, and HCV antibody with RNA follow-up answer different questions.
What does a positive hepatitis A total antibody mean?
A positive total anti-HAV or IgG anti-HAV result usually means past infection or vaccination. Acute hepatitis A is usually evaluated with IgM anti-HAV, interpreted with symptoms and exposure history.
What is the hepatitis B triple panel?
CDC recommends a hepatitis B triple panel for adults who have never been screened. It includes HBsAg, anti-HBs, and total anti-HBc to help identify current infection, past infection, vaccination immunity, or susceptibility.
Does a positive hepatitis C antibody mean current infection?
Not by itself. CDC says a reactive HCV antibody shows past or current infection and should be followed automatically by HCV RNA testing to determine whether current infection is present.
Can hepatitis tests be negative soon after exposure?
Yes. Timing matters. Early after exposure, antibodies or viral markers may not yet be detectable, and repeat or RNA-based testing may be needed depending on the virus, exposure, symptoms, and clinical context.
Do high ALT or AST levels prove viral hepatitis?
No. ALT and AST can show liver-cell injury, but they do not identify the cause. Viral hepatitis testing, medication review, alcohol history, metabolic risk, bilirubin, INR, symptoms, and imaging may all affect follow-up.